Almanack Investment Partners’s AlphaClone Alternative Alpha ETF ALFA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-8,472
Closed -$446K – 984
2022
Q2
$446K Sell
8,472
-6,070
-42% -$366K 0.04% 253
2022
Q1
$1.02M Sell
14,542
-15,079
-51% -$1.04M 0.09% 145
2021
Q4
$2.31M Buy
29,621
+3,470
+13% +$290K 0.19% 81
2021
Q3
$2.17M Buy
26,151
+3,541
+16% +$304K 0.19% 82
2021
Q2
$1.91M Buy
22,610
+3,157
+16% +$247K 0.18% 85
2021
Q1
$1.47M Buy
19,453
+12,013
+161% +$959K 0.15% 100
2020
Q4
$571K Buy
7,440
+2,650
+55% +$189K 0.07% 188
2020
Q3
$317K Buy
+4,790
New +$296K 0.04% 287

Almanack Investment Partners's ALFA Position: Q3 2022 in Review

Almanack Investment Partners sold out of AlphaClone Alternative Alpha ETF (ALFA) in Q3 2022, closing a stake of 8,472 shares — an estimated $446K sold.

Almanack Investment Partners first reported a position in ALFA in Q3 2020 and held it in 8 quarters. The position peaked at $2.31M in Q4 2021. 0 funds tracked by Wall St. Rank hold ALFA as of Q3 2022.

  • Almanack Investment Partners reported no remaining AlphaClone Alternative Alpha ETF position as of Q3 2022 after selling out during the quarter.
  • Almanack Investment Partners sold 8,472 AlphaClone Alternative Alpha ETF shares in Q3 2022, an estimated $446K.
  • Almanack Investment Partners first reported a position in AlphaClone Alternative Alpha ETF in Q3 2020 and held it in 8 quarters.
  • Almanack Investment Partners's AlphaClone Alternative Alpha ETF position peaked at $2.31M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held AlphaClone Alternative Alpha ETF as of Q3 2022.

Based on Almanack Investment Partners's 13F filing for Q3 2022, filed 15 Nov 2022.